ConductScience.org, home

Paper1716596

Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.

Kettel LM and 5 others. Fertil Steril, 1991. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Papers, record 1716596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1716596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis.
PubMed
Journal
Fertil Steril
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
4.89
iCite
Revised in PubMed
2019-07-07
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kettel LML M
2Murphy AAA A
3Mortola JFJ F
4Liu JHJ H
5Ulmann AA
6Yen SSS S

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endocrine GlandsMajor topic
EndometriosisMajor topic
MifepristoneMajor topic
Pelvic NeoplasmsMajor topic
ProgesteroneMajor topic
Adolescent
Adrenocorticotropic Hormone
Adult
Amenorrhea
Female
Hormones
Humans
Hydrocortisone
Laparoscopy
Palliative Care
Time Factors

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
38854774Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives.Reprod Med Biol2024https://conductscience.org/library/papers/38854774PubMed
34405378Hormonal treatments for endometriosis: The endocrine background.Rev Endocr Metab Disord2022https://conductscience.org/library/papers/34405378PubMed
3259956590 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies.J Mol Endocrinol2020https://conductscience.org/library/papers/32599565PubMed
32365199Selective Progesterone Receptor Modulators-Mechanisms and Therapeutic Utility.Endocr Rev2020https://conductscience.org/library/papers/32365199PubMed
32154252Mifepristone Treatment in Pregnant Murine Model Induced Mammary Gland Dysplasia and Postpartum Hypogalactia.Front Cell Dev Biol2020https://conductscience.org/library/papers/32154252PubMed
30407750Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.ChemMedChem2018https://conductscience.org/library/papers/30407750PubMed
25252652Antiprogestins in gynecological diseases.Reproduction2015https://conductscience.org/library/papers/25252652PubMed
22895965Mifepristone for uterine fibroids.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22895965PubMed
19609733Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.Endocrine2009https://conductscience.org/library/papers/19609733PubMed
12222988A benefit-risk assessment of medical treatment for uterine leiomyomas.Drug Saf2002https://conductscience.org/library/papers/12222988PubMed
11333561[After levonorgestrel, will mifepristone (RU486) be the next day-after pill?].Aten Primaria2001https://conductscience.org/library/papers/11333561PubMed
9250420Clinical pharmacokinetics of mifepristone.Clin Pharmacokinet1997https://conductscience.org/library/papers/9250420PubMed
8297920Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.J Psychiatry Neurosci1993https://conductscience.org/library/papers/8297920PubMed
7969170The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.Mol Cell Biol1994https://conductscience.org/library/papers/7969170PubMed
7962545Antioxidant: a new role for RU-486 and related compounds.J Clin Invest1994https://conductscience.org/library/papers/7962545PubMed
7682909Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.Drugs1993https://conductscience.org/library/papers/7682909PubMed
1615658RU 486 (mifepristone).West J Med1992https://conductscience.org/library/papers/1615658PubMed
1281069Mifepristone. Separating fact from fiction.Drugs1992https://conductscience.org/library/papers/1281069PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
POMC5443PubTator's text mininghttps://conductscience.org/library/genes/5443

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1716596

GET https://conductscience.org/api/papers/v1/1716596/authors